Please tell your readers about this so as not to scare them into taking medicine that they might not need. There still may be something going on with me, and I will be getting more tests to be sure ...
A new, fast and easy test could revolutionize blood transfusions-giving blood centers and hospitals a reliable way to monitor the quality of red blood cells after they sit for weeks in storage.
Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets TRBC2-positive T-cell cancers, expanding a precision approach they established ...
Cell therapy company Link Cell Therapies is launching with $60 million and a mission to develop potent CAR-T therapies that go after a range of tumors while avoiding patients' healthy tissue. The ...
LAW & ORDER: SPECIAL VICTIMS UNIT: (l-r) Ice-T as Detective Odafin "Fin" Tutuola, Kelli Giddish as Detective Amanda Rollins Virginia Sherwood/NBC There has been less of Ice-T‘s Sergeant Odafin ‘Fin’ ...
Researchers discovered a way to keep T cells from wearing out during the fight against cancer, and the approach could make immune-based treatments far more powerful. They found that tumors use a ...
T-cell engagers, especially BiTEs, show promise in treating solid tumors by targeting tumor-associated antigens and redirecting T-cell activity. Tarlatamab, targeting DLL3 in SCLC, demonstrated ...
Cabaletta Bio’s CAR-T cell therapy has eliminated the overreactive B cells of two patients with an autoimmune disease without preconditioning chemotherapy, pleasing investors and analysts while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results